A molecular diagnostic assay for detection of carbapenem-resistant Enterobacteriaceae in infectious disease diagnostics.
Manufactured by
Daejeon, South Korea
PANAGENE will always make its best efforts to develop innovative platform technologies and strive to be a global leader in the field of molecular diagnostics. We, PANAGENE Inc. have been developing and launching accurate and convenient in vitro diagnostic products consistently from Oncology to Infectious Diseases. We exercise strict quality management policy and make efforts to meet global standards and appropriate regulations for our IVD products. PANAGENE has expertise especially in cancer-related molecular diagnostics including companion diagnostics using tissue or liquid biopsy. Our advanced technology provides not only high level of detection but also simple and convenient procedure to be used easily in the front-line hospitals and clinical laboratories. (EGFR, KRAS, NRAS, BRAF, PIK3CA, IDH1, IDH2, JAK2, BCR-ABL, c-KIT, TERT, EML4-ALK, ROS1) Also we apply our platform technology to maximize multiplex capability to detect using melting curve analysis with high-level performance. (HPV, STD, CRE, TB/NTM) Lastly, we have our automation extraction system to use with molecular diagnostics kits to provide full package solution for the user. The extraction machine is 100% in house developed and optimized with our kits. During this Pandemic, we are providing the machines and extraction kits to reach out who needs the testings. (Viral, FFPE, cfDNA extraction kits) PANAGENE is pursuing open innovation and seeking opportunity for collaboration with various organizations including pharmaceutical and diagnostics companies. We always welcome organizations who are interest in our technologies and/or products. We will do our best for customer satisfaction and for realizing our vision, “Platform Technology Provider”.
✦ Product-Specific Coverage
Based on AI-matched alternatives related to this product across Suplivia's medical sourcing network.
Generated for this product
AI-matched supplier coverage based on related product alternatives.
CORIS BIOCONCEPT SRL
Belgium · 17 relevant products
Medix Biochemica Oy AB
Finland · 1 relevant product
Hangzhou Genesis Biodetection & Biocontrol Co., Ltd.
China · 4 relevant products
Jiangsu Medomics Medical Technology Co.,Ltd.
China · 2 relevant products
CLONIT SRL
Italy · 2 relevant products
Hardy Diagnostics
United States · 1 relevant product
Fosun Diagnostics (Shanghai) Co., Ltd
China · 1 relevant product
Hangzhou Biotest Biotech Co., Ltd
China · 1 relevant product
i Med Laboratories Co., Ltd.
Thailand · 1 relevant product
Hecin Scientific, Inc.
China · 1 relevant product
60 more relevant manufacturers available
Get free access to all relevant manufacturers for this product.
See all manufacturers →9 more sourcing countries available
Get free access to all sourcing countries identified for this product.
See all countries →See the full supplier coverage for this product
Get free access to all relevant manufacturers, sourcing countries, and product alternatives.
✓ Free for medical industry professionals.
from other manufacturers
from other manufacturers
12 of 113 closest product alternatives
CORIS BIOCONCEPT SRL · Belgium
Rapid diagnostic test for detection of carbapenemase-producing organisms. Enables quick identification to support infection control measures and antimicrobial stewardship practices in clinical laboratories.
Medix Biochemica Oy AB · Finland
A diagnostic test for detecting Carbapenemase-producing bacteria in clinical samples. This test is used in clinical laboratories for identification of antibiotic resistance.
Hangzhou Genesis Biodetection & Biocontrol Co., Ltd. · China
A rapid diagnostic test for the detection of carbapenemase enzymes in microorganisms. This test enables the identification of bacteria resistant to carbapenem antibiotics, which are important last-resort antimicrobials.
Jiangsu Medomics Medical Technology Co.,Ltd. · China
Lateral flow immunoassay (LFIA) combo test kit for rapid qualitative detection of carbapenem-resistant Enterobacteriaceae (CRE) strains carrying KPC, IMP, NDM, VIM, and OXA-48 resistance genes. Enables quick identification of antibiotic-resistant pathogens to guide appropriate antimicrobial therapy and infection control measures in clinical and laboratory settings.
CLONIT SRL · Italy
Lateral flow assay (LFA) test kit for rapid detection of carbapenem-resistant Enterobacteriaceae in clinical samples. The test enables quick identification of antibiotic-resistant pathogens to support appropriate infection control and treatment decisions. Results are available within minutes of sample processing.
Hardy Diagnostics · United States
Biochemical test for detection of five bacterial carbapenemase enzymes in Enterobacterales and other gram-negative bacteria. Supports antimicrobial susceptibility assessment in clinical microbiology.
CORIS BIOCONCEPT SRL · Belgium
Rapid blood culture test for detecting carbapenemase-producing organisms, enabling quick identification to support infection control and antimicrobial stewardship protocols. User-friendly assay with short turnaround time for routine laboratory implementation.
Hangzhou Genesis Biodetection & Biocontrol Co., Ltd. · China
A rapid diagnostic test for the detection of MCR-1 enzyme, which is associated with colistin resistance in bacteria. This test enables quick identification of this clinically important resistance mechanism.
Fosun Diagnostics (Shanghai) Co., Ltd · China
A colloidal gold immunochromatographic assay kit designed to detect carbapenemase-producing organisms. This diagnostic test identifies bacteria that produce carbapenemase enzymes, which confer resistance to carbapenem antibiotics.
Hangzhou Biotest Biotech Co., Ltd · China
A diagnostic test for detecting infectious diseases. This product is part of the company's diagnostic testing portfolio for clinical use.
i Med Laboratories Co., Ltd. · Thailand
Diagnostic test for identification of infectious disease pathogens. Assesses multiple factors including pathogen type and quantity for clinical diagnosis.
Hecin Scientific, Inc. · China
PCR-based nucleic acid test kit for rapid detection and identification of Clostridium difficile in clinical specimens. Employs fluorescence probe methodology for sensitive and specific diagnosis of C. difficile infection in gastrointestinal disease assessment. Suitable for use on standard PCR platforms in clinical microbiology laboratories.
101 more product alternatives available
Create a free account to compare more product alternatives and supplier options.
© 2026 Suplivia · Home · Browse Products